About Protypia
Protypia is a company based in Brentwood (United States) founded in 2017 was acquired by Inotiv in July 2022. Protypia operates in a competitive market with competitors including Nautilus Biotechnology, Somalogic, ProteinSimple, Amunix and Dynamic Biosensors, among others.
- Headquarter Brentwood, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Protypia
Detailed funding history for Protypia
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Protypia
Protypia has secured backing from 1 investor. Prominent investors backing the company include Inotiv Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Clinical development and regulatory services are provided by Inotiv.
|
Locked | Locked | Locked |
Investor details for Protypia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Protypia
Investment portfolio details for Protypia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Protypia
Detailed financials for Protypia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Protypia Comparisons
Peer comparison for Protypia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Protypia
Protypia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nautilus Biotechnology, Somalogic, ProteinSimple, Amunix and Dynamic Biosensors, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A proteomics platform is developed for analyzing the human proteome.
|
|
| Locked | Locked | Locked |
Protein-based assays are developed for life science research.
|
|
| Locked | Locked | Locked |
Provider tools to help researchers with protein analysis
|
|
| Locked | Locked | Locked |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| Locked | Locked | Locked |
Label-free solutions for molecular interactions and biophysical analysis are provided.
|
|
| Locked | Locked | Locked |
Proteomics services are delivered via discovery and targeted platforms.
|
Detailed competitors of Protypia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Protypia
Complete news archive for Protypia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Protypia
Protypia was founded in 2017.
Protypia is headquartered in Brentwood, United States.
Protypia was founded in 2017 and is based in Brentwood, United States. Analytical support utilizing mass spectrometry is delivered for drug safety and therapeutic development within the biotechnology sector. Services encompass the examination of on-target and off-target protein interactions in covalent drugs, assessment of immune checkpoint proteins influencing immunotherapy responses, and proteogenomics analysis applied to cancer studies. Operations focus on precise molecular insights for pharmaceutical applications.
Protypia's top competitors include Somalogic, Nautilus Biotechnology and Elektrofi.
Protypia has 1 investor. Key investors include Inotiv Co.